Aperiam Bio
PrivateLast Round
Seed
Nov 29, 2023
Total Funding Raised
$9M
Company Overview
Aperiam Bio is a biotechnology company that applies a patented, 3D computer vision algorithm to identify improvements to proteins, making them more effective and durable for industrial and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Computer Vision, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aperiam Bio Comparables
Compare Aperiam Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pando Bioscience | 83% | |
| Amineo | 81% | |
| Cambrium | 81% | |
Aperiam Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 29, 2023 |
Aperiam Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OMX Ventures | Seed |
| Axial VC | Seed |
| Civilization Ventures | Seed |
| KdT Ventures | Seed |
| Axial VC | Seed |
Aperiam Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aperiam Bio's valuation, stock price, and market status.